Answers are grounded in this paper and cite their sources.
The peroxisome proliferator-activated receptor γ (PPARγ) coactivator 1α (PGC-1α) is a highly inducible transcriptional coactivator implicated in the coordinate regulation of genes encoding enzymes involved in hepatic fatty acid oxidation, oxidative phosphorylation, and gluconeogenesis. The present study sought to assess the effects of chronic PGC-1α deficiency on metabolic flux through the hepatic gluconeogenic, fatty acid oxidation, and tricarboxylic acid cycle pathways. To this end, hepatic metabolism was assessed in wild-type (WT) and PGC-1α–/– mice using isotopomer-based NMR with complementary gene expression analyses. Hepatic glucose production was diminished in PGC-1α–/– livers coincident with reduced gluconeogenic flux from phosphoenolpyruvate. Surprisingly, the expression of PGC-1α target genes involved in gluconeogenesis was unaltered in PGC-1α–/– compared with WT mice under fed and fasted conditions. Flux through tricarboxylic acid cycle and mitochondrial fatty acid β-oxidation pathways was also diminished in PGC-1α–/– livers. The expression of multiple genes encoding tricarboxylic acid cycle and oxidative phosphorylation enzymes was significantly depressed in PGC-1α–/– mice and was activated by PGC-1α overexpression in the livers of WT mice. Collectively, these findings suggest that chronic whole-animal PGC-1α deficiency results in defects in hepatic glucose production that are secondary to diminished fatty acid β-oxidation and tricarboxylic acid cycle flux rather than abnormalities in gluconeogenic enzyme gene expression per se. The peroxisome proliferator-activated receptor γ (PPARγ) coactivator 1α (PGC-1α) is a highly inducible transcriptional coactivator implicated in the coordinate regulation of genes encoding enzymes involved in hepatic fatty acid oxidation, oxidative phosphorylation, and gluconeogenesis. The present study sought to assess the effects of chronic PGC-1α deficiency on metabolic flux through the hepatic gluconeogenic, fatty acid oxidation, and tricarboxylic acid cycle pathways. To this end, hepatic metabolism was assessed in wild-type (WT) and PGC-1α–/– mice using isotopomer-based NMR with complementary gene expression analyses. Hepatic glucose production was diminished in PGC-1α–/– livers coincident with reduced gluconeogenic flux from phosphoenolpyruvate. Surprisingly, the expression of PGC-1α target genes involved in gluconeogenesis was unaltered in PGC-1α–/– compared with WT mice under fed and fasted conditions. Flux through tricarboxylic acid cycle and mitochondrial fatty acid β-oxidation pathways was also diminished in PGC-1α–/– livers. The expression of multiple genes encoding tricarboxylic acid cycle and oxidative phosphorylation enzymes was significantly depressed in PGC-1α–/– mice and was activated by PGC-1α overexpression in the livers of WT mice. Collectively, these findings suggest that chronic whole-animal PGC-1α deficiency results in defects in hepatic glucose production that are secondary to diminished fatty acid β-oxidation and tricarboxylic acid cycle flux rather than abnormalities in gluconeogenic enzyme gene expression per se. Flux through hepatic gluconeogenesis, fatty acid oxidation (FAO), 3The abbreviations used are: FAO, fatty acid oxidation; WT, wild-type; OXPHOS, oxidative phosphorylation; PC, pyruvate carboxylase; PPAR, peroxisome proliferator-activated receptor; PEPCK, phosphoenolpyruvate carboxykinase; GFP, green fluorescent protein; MAG, monoacetone glucose; GNGglycerol, gluconeogenesis from glycerol; PEP, P-enolpyruvate; CS, citrate synthase; AcAc, acetoacetate; BHB, β-hydroxybutyrate; HPLC, high pressure liquid chromatography; RT, reverse transcription; Glc-6-P, glucose-6-phosphatase; IDH, isocitrate dehydrogenase; SDH, succinate dehydrogenase; MDH, malate dehydrogenase; CytC, cytochrome c; COX2, CytC oxidase 2. tricarboxylic acid cycle, and mitochondrial oxidative phosphorylation (OXPHOS) pathways can be modulated at multiple regulatory levels. Substrate availability, post-translational modification, and transcriptional regulation of genes encoding enzymes at various points can influence the capacity for, and the rate of flux through, each of these pathways. Moreover, flux through one pathway has an inevitable impact on the flux of the others. For instance, mitochondrial FAO is the principal source of energy in the hepatocyte, impacting the amount of chemical work that can be performed by the liver. Furthermore, the tricarboxylic acid cycle not only oxidizes acetyl-CoA generated by β-oxidation and produces reducing equivalents for ATP synthesis but also supplies carbons necessary for gluconeogenesis through pyruvate carboxylase (PC) and P-enolpyruvate carboxykinase (PEPCK). Thus, the tricarboxylic acid cycle is a critical hub linking FAO with gluconeogenesis and OXPHOS pathways. Recent work has shown that the peroxisome proliferator-activated receptor γ (PPARγ) coactivator-1α (PGC-1α) is a highly inducible transcriptional coactivator that integrates multiple interconnected metabolic pathways in liver (1Lin J. Handschin C. Spiegelman B.M. Cell Metab. 2005; 1: 361-370Abstract Full Text Full Text PDF PubMed Scopus (1716) Google Scholar). PGC-1α controls transcription of genes involved in hepatic gluconeogenesis, fatty acid catabolism, oxidative phosphorylation (OXPHOS), and mitochondrial biogenesis (1Lin J. Handschin C. Spiegelman B.M. Cell Metab. 2005; 1: 361-370Abstract Full Text Full Text PDF PubMed Scopus (1716) Google Scholar, 2Kelly D.P. Scarpulla R.C. Genes Dev. 2004; 18: 357-368Crossref PubMed Scopus (1020) Google Scholar, 3Spiegelman B.M. Heinrich R. Cell. 2004; 119: 157-167Abstract Full Text Full Text PDF PubMed Scopus (305) Google Scholar). Although PGC-1α was originally identified in a yeast two-hybrid screen of PPARγ-interacting factors in a brown adipocyte cDNA library (4Puigserver P. Wu Z. Park C.W. Graves R. Wright M. Spiegelman B.M. Cell. 1998; 92: 829-839Abstract Full Text Full Text PDF PubMed Scopus (3154) Google Scholar), it is now known to coactivate myriad nuclear receptor and non-nuclear receptor transcription factors in a variety of cell types (1Lin J. Handschin C. Spiegelman B.M. Cell Metab. 2005; 1: 361-370Abstract Full Text Full Text PDF PubMed Scopus (1716) Google Scholar). Expression is enriched in tissues with a high capacity for mitochondrial OXPHOS, including heart, skeletal muscle, and brown adipose tissue (1Lin J. Handschin C. Spiegelman B.M. Cell Metab. 2005; 1: 361-370Abstract Full Text Full Text PDF PubMed Scopus (1716) Google Scholar, 4Puigserver P. Wu Z. Park C.W. Graves R. Wright M. Spiegelman B.M. Cell. 1998; 92: 829-839Abstract Full Text Full Text PDF PubMed Scopus (3154) Google Scholar). Although hepatic PGC-1α levels are relatively low in normal, ad libitum-fed mice, its expression is robustly induced by acute food deprivation or diabetes mellitus (5Herzig S. Long F. Jhala U.S. Hedrick S. Quinn R. Bauer A. Rudolph D. Schutz G. Yoon C. Puigserver P. Spiegelman B. Montminy M. Nature. 2001; 413: 179-183Crossref PubMed Scopus (1164) Google Scholar, 6Yoon J.C. Puigserver P. Chen G. Donovan J. Wu Z. Rhee J. Adelmant G. Stafford J. Kahn C.R. Granner D.K. Newgard C.B. Spiegelman B.M. Nature. 2001; 413: 131-138Crossref PubMed Scopus (1551) Google Scholar), states when rates of fatty acid oxidation and gluconeogenesis are increased. Overexpression of PGC-1α in liver transcriptionally activates genes involved in hepatic gluconeogenesis, fatty acid catabolism, and OXPHOS (2Kelly D.P. Scarpulla R.C. Genes Dev. 2004; 18: 357-368Crossref PubMed Scopus (1020) Google Scholar, 3Spiegelman B.M. Heinrich R. Cell. 2004; 119: 157-167Abstract Full Text Full Text PDF PubMed Scopus (305) Google Scholar, 6Yoon J.C. Puigserver P. Chen G. Donovan J. Wu Z. Rhee J. Adelmant G. Stafford J. Kahn C.R. Granner D.K. Newgard C.B. Spiegelman B.M. Nature. 2001; 413: 131-138Crossref PubMed Scopus (1551) Google Scholar, 7Rhee J. Inoue Y. Yoon J.C. Puigserver P. Fan M. Gonzalez F.J. Spiegelman B.M. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 4012-4017Crossref PubMed Scopus (480) Google Scholar), whereas acute loss of function (adenovirus-driven RNA interference) markedly down-regulates expression of genes involved in each of these processes (8Koo S.H. Satoh H. Herzig S. Lee C.H. Hedrick S. Kulkarni R. Evans R.M. Olefsky J. Montminy M. Nat. Med. 2004; 10: 530-534Crossref PubMed Scopus (482) Google Scholar). Similarly, liver-specific PGC-1α gene deletion in mice impairs the expression of gluconeogenic genes in response to acute food deprivation (9Handschin C. Lin J. Rhee J. Peyer A.K. Chin S. Wu P.H. Meyer U.A. Spiegelman B.M. Cell. 2005; 122: 505-515Abstract Full Text Full Text PDF PubMed Scopus (302) Google Scholar). Surprisingly, recent studies of two independently derived strains of mice in which the PGC-1α gene was constitutively disrupted in a whole-animal fashion (PGC-1α–/– mice) have shown that the expression of many known PGC-1α target genes was unaltered (10Leone T.C. Lehman J.J. Finck B.N. Schaeffer P.J. Wende A.R. Boudina S. Courtois M. Wozniak D.F. Sambandam N. Bernal-Mizrachi C. Chen Z. Holloszy J.O. Medeiros D.M. Schmidt R.E. Saffitz J.E. Abel E.D. Semenkovich C.F. Kelly D.P. PLoS Biol. 2005; PubMed Scopus Google or only in liver J. Wu P.H. J. S. C.R. R.M. M. Donovan Wu Z. Fan S. D. Spiegelman B.M. Cell. 2004; 119: Full Text Full Text PDF PubMed Scopus Google Scholar). rates of fatty acid β-oxidation (10Leone T.C. Lehman J.J. Finck B.N. Schaeffer P.J. Wende A.R. Boudina S. Courtois M. Wozniak D.F. Sambandam N. Bernal-Mizrachi C. Chen Z. Holloszy J.O. Medeiros D.M. Schmidt R.E. Saffitz J.E. Abel E.D. Semenkovich C.F. Kelly D.P. PLoS Biol. 2005; PubMed Scopus Google Scholar), mitochondrial (10Leone T.C. Lehman J.J. Finck B.N. Schaeffer P.J. Wende A.R. Boudina S. Courtois M. Wozniak D.F. Sambandam N. Bernal-Mizrachi C. Chen Z. Holloszy J.O. Medeiros D.M. Schmidt R.E. Saffitz J.E. Abel E.D. Semenkovich C.F. Kelly D.P. PLoS Biol. 2005; PubMed Scopus Google Scholar), and J. Wu P.H. J. S. C.R. R.M. M. Donovan Wu Z. Fan S. D. Spiegelman B.M. Cell. 2004; 119: Full Text Full Text PDF PubMed Scopus Google significantly diminished in from PGC-1α–/– mice. Moreover, one PGC-1α–/– hepatic a to diminished capacity for FAO (10Leone T.C. Lehman J.J. Finck B.N. Schaeffer P.J. Wende A.R. Boudina S. Courtois M. Wozniak D.F. Sambandam N. Bernal-Mizrachi C. Chen Z. Holloszy J.O. Medeiros D.M. Schmidt R.E. Saffitz J.E. Abel E.D. Semenkovich C.F. Kelly D.P. PLoS Biol. 2005; PubMed Scopus Google Scholar). Although studies have PGC-1α in the transcriptional of genes encoding enzymes involved in gluconeogenesis, FAO, and the tricarboxylic acid cycle, is known the impact of this coactivator on metabolic flux through these pathways in liver. PGC-1α–/– mice a to this the liver of PGC-1α–/– mice by and NMR studies with gene expression multiple genes encoding enzymes in the hepatic metabolic pathways. Surprisingly, in rates of gluconeogenic flux in liver of fasted PGC-1α–/– mice, gluconeogenic gene expression was under fed and fasted conditions. of fatty acid β-oxidation and tricarboxylic acid cycle flux also in PGC-1α–/– mice, which with diminished expression of tricarboxylic acid cycle enzymes and genes involved in these suggest that gluconeogenic defects in PGC-1α–/– mice are secondary to in mitochondrial oxidative metabolism and tricarboxylic acid cycle but not gluconeogenic enzyme and of PGC-1α–/– mice has (10Leone T.C. Lehman J.J. Finck B.N. Schaeffer P.J. Wende A.R. Boudina S. Courtois M. Wozniak D.F. Sambandam N. Bernal-Mizrachi C. Chen Z. Holloszy J.O. Medeiros D.M. Schmidt R.E. Saffitz J.E. Abel E.D. Semenkovich C.F. Kelly D.P. PLoS Biol. 2005; PubMed Scopus Google Scholar). PGC-1α–/– mice with and wild-type (WT) mice studies performed with mice that for or ad to For mice with the expression of or PGC-1α C. S. C. Finck B.N. T.C. Kelly D.P. Semenkovich C.F. Nat. Med. 2003; PubMed Scopus Google and for tissue was by and PubMed Scopus Google using liver tissue from WT or PGC-1α–/– mice fasted for and from mice N. M. C. A. S. J. C.R. J. Biol. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). a was performed to the liver and The liver was and the was The hepatic and and the through the was with a at in a The liver was in a at was and on The was of and was by of at and at for performed for and the of was for NMR and and production was in a of under the WT and the liver was and at and NMR was from the and to its monoacetone glucose N. M. C. A. S. J. C.R. J. Biol. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). was by C.R. J. 2001; PubMed Google Scholar, M. M. C.R. 2003; PubMed Scopus Google and C.R. J. 2001; PubMed Google NMR at using a to and in the using the in the NMR from the NMR and of glucose N. M. C. A. S. J. C.R. J. Biol. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar, C.R. 2004; PubMed Scopus Google Scholar). NMR of used to the of glucose at the and these used to the of glucose production from gluconeogenesis from and gluconeogenesis from P-enolpyruvate from or the tricarboxylic acid cycle C.R. J. 2001; PubMed Google Scholar, J. J. Google Scholar, J. J. PubMed Scopus Google Scholar). by the by glucose production N. M. C. A. S. J. C.R. J. Biol. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar, C.R. 2004; PubMed Scopus Google Scholar). and pyruvate from the in the NMR of using N. M. C. A. S. J. C.R. J. Biol. 2004; Full Text Full Text PDF PubMed Scopus Google C.R. 2004; PubMed Scopus Google R. C.R. PubMed Scopus Google Scholar). Hepatic be by pathways under in the is by flux through but also have for instance, from the For to this PEPCK, it the and is a of The of by pyruvate from the enzyme or from pyruvate and it be that these two pathways be from each using the The and pyruvate is to gluconeogenesis from PEP, which the by glucose production and the NMR to be to the the tricarboxylic acid β-oxidation was from and citrate of fatty acid β-oxidation under the that citrate flux and the only of acetyl-CoA the β-oxidation is in of is in and β-oxidation is in The of and is by are generated per for and with acid to was by A. B. J. of Scholar), and these used to the rate of hepatic glucose and by the of J. J. PubMed Scopus Google Scholar). The rate of and production to the rate of liver tissue was and acid for of AcAc, of and NMR in the tissue by J. J. PubMed Scopus Google Scholar). The for and was performed by F. G. PubMed Scopus Google on a with and reverse and of from WT and PGC-1α–/– mice Z. G. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar). For gene expression with for with or and cDNA was generated by reverse transcription using hepatic was performed using the and the green to and are shown in of target by the levels of using of to or are with a from PGC-1α–/– mice and controls and with a for The PGC-1α–/– livers glucose the of the To the source of the glucose in these was in the and the glucose was by NMR a of gluconeogenesis and a of to glucose production J. J. Google in PGC-1α–/– livers compared with WT controls was in the C.R. J. 2001; PubMed Google that the of glucose production to gluconeogenesis from was the J. J. PubMed Scopus Google was significantly in PGC-1α–/– a in gluconeogenesis from a of glucose production The that was a source of glucose a was but with a in liver in fasted PGC-1α–/– mice fasted WT mice suggest that hepatic is in PGC-1α–/– mice to for to for a in gluconeogenic flux levels low compared with the fed to which pathways to glucose production in the PGC-1α–/– the flux through GNGglycerol, and and in pathways was the of glucose derived from in the PGC-1α–/– was in rates of PGC-1α–/– and WT livers to the in glucose the flux from to glucose was not significantly the WT and PGC-1α–/– livers. flux through was in PGC-1α–/– livers that the in glucose was at the of gluconeogenesis from that through the tricarboxylic acid cycle or the of and To flux through the tricarboxylic acid cycle and pyruvate in by NMR of the glucose from PGC-1α–/– and livers. flux through the pathway was in PGC-1α–/– livers compared with WT that flux was also that PGC-1α–/– livers flux through pyruvate or pyruvate by NMR be a response to flux to by from this the pyruvate gluconeogenesis be to in the PGC-1α–/– livers. PGC-1α for or Expression of NMR that gluconeogenesis, the is in PGC-1α–/– mice, the expression of genes encoding PEPCK, and in PGC-1α–/– livers. Surprisingly, the hepatic expression of PEPCK, Glc-6-P, and was and robustly induced by in WT and PGC-1α–/– mice The expression of gluconeogenic enzymes was also in with and which is known to PGC-1α and gluconeogenic gene PGC-1α deficiency not the of or gene expression in response to this Collectively, these that PGC-1α is not for the of gluconeogenic gene expression in response to acute or gluconeogenic and suggest the of regulatory of gluconeogenic enzymes in PGC-1α–/– levels of and from from WT and PGC-1α–/– mice by green in with or and for to RNA are to WT and to RNA levels in the PGC-1α is a transcriptional of fatty acid catabolism, OXPHOS, and mitochondrial biogenesis (2Kelly D.P. Scarpulla R.C. Genes Dev. 2004; 18: 357-368Crossref PubMed Scopus (1020) Google Scholar, 3Spiegelman B.M. Heinrich R. Cell. 2004; 119: 157-167Abstract Full Text Full Text PDF PubMed Scopus (305) Google Scholar), flux through pathways for hepatic energy was also that hepatic in the PGC-1α–/– livers was reduced by compared with livers and production was in the PGC-1α–/– liver compared with controls of the glucose a of tricarboxylic acid cycle citrate flux in PGC-1α–/– livers WT controls β-oxidation of was also by in the PGC-1α–/– liver which is with using in (10Leone T.C. Lehman J.J. Finck B.N. Schaeffer P.J. Wende A.R. Boudina S. Courtois M. Wozniak D.F. Sambandam N. Bernal-Mizrachi C. Chen Z. Holloszy J.O. Medeiros D.M. Schmidt R.E. Saffitz J.E. Abel E.D. Semenkovich C.F. Kelly D.P. PLoS Biol. 2005; PubMed Scopus Google Scholar). findings a to loss of PGC-1α flux through β-oxidation and the of the tricarboxylic acid cycle mitochondrial To the mitochondrial was liver tissue was and for the and Surprisingly, PGC-1α–/– livers a compared with an in the P. J. PubMed Scopus Google Scholar). reduced are with hepatic in which energy production energy which findings of tricarboxylic acid cycle and β-oxidation in the PGC-1α–/– liver. To this impact energy and by of the liver The of and by in the PGC-1α–/– liver but not and in the energy PGC-1α the Expression of and OXPHOS in reduced rates of FAO in from PGC-1α–/– mice, the expression of genes involved in FAO and was by PGC-1α deficiency (10Leone T.C. Lehman J.J. Finck B.N. Schaeffer P.J. Wende A.R. Boudina S. Courtois M. Wozniak D.F. Sambandam N. Bernal-Mizrachi C. Chen Z. Holloszy J.O. Medeiros D.M. Schmidt R.E. Saffitz J.E. Abel E.D. Semenkovich C.F. Kelly D.P. PLoS Biol. 2005; PubMed Scopus Google Scholar), which is the in β-oxidation the expression of genes encoding tricarboxylic acid cycle and OXPHOS that the expression of the tricarboxylic acid cycle citrate isocitrate and succinate was significantly diminished in liver of PGC-1α mice whereas the expression of malate was not has in tissues of PGC-1α–/– mice, the expression of genes encoding enzymes involved in OXPHOS, including cytochrome CytC oxidase and the of ATP was also diminished the of tricarboxylic acid cycle deficiency in the of hepatic energy and glucose by PGC-1α was to the expression of tricarboxylic acid cycle mice with an the expression of PGC-1α and hepatic gene expression from the the expression of CS, SDH, IDH, and was robustly activated by PGC-1α overexpression in the livers of mice The expression of CytC, COX2, and was also induced by PGC-1α Collectively, these and studies multiple enzymes in the tricarboxylic acid cycle target genes of PGC-1α in liver. of recent studies has shown that the of transcriptionally enzymes involved in mitochondrial OXPHOS, FAO, and glucose (1Lin J. Handschin C. Spiegelman B.M. Cell Metab. 2005; 1: 361-370Abstract Full Text Full Text PDF PubMed Scopus (1716) Google Scholar, 2Kelly D.P. Scarpulla R.C. Genes Dev. 2004; 18: 357-368Crossref PubMed Scopus (1020) Google Scholar, 3Spiegelman B.M. Heinrich R. Cell. 2004; 119: 157-167Abstract Full Text Full Text PDF PubMed Scopus (305) Google Scholar). with that chronic PGC-1α deficiency to in hepatic tricarboxylic acid cycle, and gluconeogenic metabolic flux through these pathways to in the expression of multiple enzymes in the tricarboxylic acid cycle and OXPHOS pathways. in hepatic gluconeogenic and mitochondrial fatty acid β-oxidation flux in PGC-1α–/– mice not with expression of enzymes involved in gluconeogenesis or fatty acid on these that the gluconeogenic and β-oxidation defects in PGC-1α–/– mice are secondary to tricarboxylic acid cycle, OXPHOS, or mitochondrial and suggest that these findings by which diminished PGC-1α glucose and fatty acid The hepatic PGC-1α is activated in types and of diabetes mellitus (5Herzig S. Long F. Jhala U.S. Hedrick S. Quinn R. Bauer A. Rudolph D. Schutz G. Yoon C. Puigserver P. Spiegelman B. Montminy M. Nature. 2001; 413: 179-183Crossref PubMed Scopus (1164) Google Scholar, 6Yoon J.C. Puigserver P. Chen G. Donovan J. Wu Z. Rhee J. Adelmant G. Stafford J. Kahn C.R. Granner D.K. Newgard C.B. Spiegelman B.M. Nature. 2001; 413: 131-138Crossref PubMed Scopus (1551) Google Scholar). PGC-1α transcriptionally activates the expression of genes encoding gluconeogenic PGC-1α is to to hepatic glucose production in the of RNA of hepatic PGC-1α glucose in a of diabetes (8Koo S.H. Satoh H. Herzig S. Lee C.H. Hedrick S. Kulkarni R. Evans R.M. Olefsky J. Montminy M. Nat. Med. 2004; 10: 530-534Crossref PubMed Scopus (482) Google Scholar). to the in the expression of PGC-1α and target genes involved in OXPHOS is diminished in the skeletal of A. S. J. Puigserver P. M. N. N. P. Spiegelman B. D. Nat. 2003; PubMed Scopus Google Scholar). skeletal PGC-1α a in the of diabetes or is a secondary of metabolic of the is it has that PGC-1α and the of skeletal PGC-1α–/– mice on and are high (10Leone T.C. Lehman J.J. Finck B.N. Schaeffer P.J. Wende A.R. Boudina S. Courtois M. Wozniak D.F. Sambandam N. Bernal-Mizrachi C. Chen Z. Holloszy J.O. Medeiros D.M. Schmidt R.E. Saffitz J.E. Abel E.D. Semenkovich C.F. Kelly D.P. PLoS Biol. 2005; PubMed Scopus Google Scholar, J. Wu P.H. J. S. C.R. R.M. M. Donovan Wu Z. Fan S. D. Spiegelman B.M. Cell. 2004; 119: Full Text Full Text PDF PubMed Scopus Google Scholar). findings to the effects of PGC-1α deficiency on hepatic metabolic PGC-1α hepatic glucose a principal of glucose The in hepatic glucose production in the of PGC-1α–/– mice. The hepatic metabolic of mice is of mice for a transcription of which also defects in hepatic fatty acid oxidation and glucose production A. B. F. J. Biol. 2004; Full Text Full Text PDF PubMed Scopus Google and are B.N. Bernal-Mizrachi C. Sambandam N. Holloszy J.O. Semenkovich C.F. Kelly D.P. Cell Metab. 2005; 1: Full Text Full Text PDF PubMed Scopus Google Scholar, Bernal-Mizrachi C. S. C. F. T.C. Kelly D.P. Semenkovich C.F. J. 2001; PubMed Scopus Google Scholar, M. C. P. J. Gonzalez F.J. J.C. G. B. 2001; PubMed Scopus Google Scholar). mice hepatic and expression under A. B. F. J. Biol. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar, S. J. Gonzalez F.J. B. J. PubMed Scopus Google but are T.C. Kelly D.P. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar). that defects in mitochondrial metabolism the defects in hepatic gluconeogenesis in PGC-1α–/– and mice. is by of mitochondrial energy For of β-oxidation enzymes to D.M. P. J. Proc. Natl. Acad. Sci. U. S. A. 1998; PubMed Scopus Google Scholar, H. Y. S. M. D. P. J. 2001; PubMed Scopus Google Scholar), whereas with in mitochondrial FAO or OXPHOS present with secondary to defects in gluconeogenesis 1998; PubMed Scopus Google Scholar, PubMed Scopus Google Scholar, in Google Scholar). The tricarboxylic acid cycle, or that to this metabolic in this and is and in mice with a liver-specific of PEPCK, tricarboxylic acid cycle flux is N. M. C. A. S. J. C.R. J. Biol. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar), of tricarboxylic acid cycle enzymes P. M. P. C.R. 2003; PubMed Scopus Google Scholar). Collectively, these studies that to and tricarboxylic acid cycle flux are N. M. C. A. S. J. C.R. J. Biol. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar, N. J. M. C. A. C.R. J. PubMed Scopus Google Scholar, P. J. D.F. Metab. 2005; PubMed Scopus Google and the of hepatic energy and gluconeogenic pathways. in the PGC-1α–/– hepatic energy production the of gluconeogenesis. of to which in the and results in production of was in PGC-1α–/– livers. the of gluconeogenic enzymes PGC-1α overexpression J.C. Puigserver P. Chen G. Donovan J. Wu Z. Rhee J. Adelmant G. Stafford J. Kahn C.R. Granner D.K. Newgard C.B. Spiegelman B.M. Nature. 2001; 413: 131-138Crossref PubMed Scopus (1551) Google Scholar), that PGC-1α is not for expression of these when PGC-1α is is work has that liver-specific PGC-1α deficiency the of and (9Handschin C. Lin J. Rhee J. Peyer A.K. Chin S. Wu P.H. Meyer U.A. Spiegelman B.M. Cell. 2005; 122: 505-515Abstract Full Text Full Text PDF PubMed Scopus (302) Google Scholar). RNA of PGC-1α in liver also a of gluconeogenic enzyme gene expression (8Koo S.H. Satoh H. Herzig S. Lee C.H. Hedrick S. Kulkarni R. Evans R.M. Olefsky J. Montminy M. Nat. Med. 2004; 10: 530-534Crossref PubMed Scopus (482) Google Scholar). the expression of gluconeogenic enzymes in the two of whole-animal PGC-1α deficiency was unaltered or J. Wu P.H. J. S. C.R. R.M. M. Donovan Wu Z. Fan S. D. Spiegelman B.M. Cell. 2004; 119: Full Text Full Text PDF PubMed Scopus Google Scholar). it be that gluconeogenic gene expression in response to and was in the PGC-1α–/– J. Wu P.H. J. S. C.R. R.M. M. Donovan Wu Z. Fan S. D. Spiegelman B.M. Cell. 2004; 119: Full Text Full Text PDF PubMed Scopus Google Scholar). is that the in gluconeogenic gene expression the various of PGC-1α deficiency are by whole-animal liver-specific deficiency or are to the of PGC-1α The from the two whole-animal suggest by with of to PGC-1α and have identified of the Although with PGC-1α in its effects on mitochondrial FAO and OXPHOS, the has effects on gluconeogenic and gene expression J. Inoue Y. Yoon J.C. Puigserver P. Fan M. Gonzalez F.J. Spiegelman B.M. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 4012-4017Crossref PubMed Scopus (480) Google Scholar, J. R. Wu P.H. Handschin C. S. M. P. Newgard C.B. Spiegelman B.M. Cell. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). Overexpression of to a gluconeogenic response and with and transcription factors and expression J. Inoue Y. Yoon J.C. Puigserver P. Fan M. Gonzalez F.J. Spiegelman B.M. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 4012-4017Crossref PubMed Scopus (480) Google Scholar). To the effects of the coactivator on gluconeogenesis have not a transcriptional coactivator of the PGC-1α has shown to gluconeogenesis in fasted liver S. Hedrick S. F. P. H. Montminy M. Nature. 2005; PubMed Scopus Google Scholar). the of the transcriptional for PGC-1α to the expression of gluconeogenic The that tricarboxylic acid cycle enzymes are of PGC-1α is not that PGC-1α controls many of mitochondrial oxidative was in skeletal P. J. D. Z. Newgard C.B. D.M. J. Biol. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar), PGC-1α multiple pathways tricarboxylic acid cycle, and to the capacity of the ATP synthesis pathway of the findings suggest that PGC-1α deficiency to a coordinate of each of these metabolic pathways and the critical that PGC-1α in energy in the liver. PGC-1α loss of function hepatic expression of enzymes in the tricarboxylic acid cycle and the PGC-1α deficiency not impact the expression of known PGC-1α target genes involved in fatty acid β-oxidation or gluconeogenesis, in the transcriptional of these pathways in response to chronic PGC-1α defects of the tricarboxylic acid cycle and OXPHOS pathways flux through fatty acid the tricarboxylic acid cycle, and studies of PGC-1α and pathways that be by PGC-1α in including and P. Kelly for PGC-1α–/– mice and for critical also and for with
No takes yet. Share an insight, caveat, or question.
Burgess et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: